Results 121 to 130 of about 52,376 (272)

Efgartigimod Followed by Telitacicept in Adult Generalized Myasthenia Gravis: A Retrospective Case Series [PDF]

Yuan Zhang,1,* Zheyu Fang,1,* Yaping Liu,2,* Bingbing Wan,1 Qiaoyi Zhang,1 Xi Qu,1 Shengli Pan,1 Yu Zhang,1 Yilin Dai,1 Shiyin Yang,1 Jia Li,1 Xu Zhang1 1Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University ...
Liu Y, Wan B, Fang Z, Li J, Pan S, Zhang Y, Zhang X, Qu X, Yang S, Zhang Q, Dai Y   +10 more
core  

Acquired myasthenia gravis in childhood.

, 2010
PURPOSE OF REVIEW: This review discusses recent studies on myasthenia gravis with onset in childhood (juvenile myasthenia gravis) and neonatal myasthenia gravis.
Evoli, Amelia, Amelia Evoli
core   +1 more source

Cardiovascular toxicity from immune checkpoint inhibitor therapy: an inflammatory continuum

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitor (ICI) therapy has markedly improved outcomes in advanced malignancies but has also revealed a distinct spectrum of cardiovascular immune‐related adverse events. Myocarditis represents the most severe manifestation, while non‐inflammatory left ventricular dysfunction and vascular inflammation have emerged as additional ...
Fabrice Reyes, Florian Buehning, Tobias Lerchner, Julia Vogel, Raluca I. Mincu, Matthias Totzeck, Tienush Rassaf, Lars Michel   +7 more
wiley   +1 more source

Identifying patients at risk for myasthenic crisis with hemogram and inflammation-related laboratory parameters – a pilot study

Frontiers in Neurology
BackgroundMyasthenia gravis (MG) is a rare autoimmune disease characterized by fatigable weakness of the voluntary muscles and can exacerbate to life-threatening myasthenic crisis (MC), requiring intensive care treatment.
Anne Mehnert, Sivan Bershan, Jil Kollmus-Heege, Lea Gerischer, Lea Gerischer, Meret Luise Herdick, Meret Luise Herdick, Sarah Hoffmann, Sarah Hoffmann, Sophie Lehnerer, Sophie Lehnerer, Sophie Lehnerer, Franziska Scheibe, Frauke Stascheit, Frauke Stascheit, Maike Stein, Maike Stein, Alastair M. Buchan, Alastair M. Buchan, Andreas Meisel, Andreas Meisel, Andreas Meisel, Annette Aigner, Annette Aigner, Philipp Mergenthaler, Philipp Mergenthaler, Philipp Mergenthaler   +26 more
doaj   +1 more source

Associations of Weight and Glucose Levels With Myasthenia Gravis: A Two-Step, Two-Sample Mendelian Randomization and Retrospective Case-Control Study. [PDF]

Brain Behav
In a two‐step, two‐sample Mendelian randomization framework, genetically predicted higher weight was associated with higher odds of myasthenia gravis (MG; OR = 1.67), whereas higher glucose levels showed an inverse association with MG (OR = 0.50). Genetically predicted higher weight was also associated with higher glucose levels (β = 0.06), and the MR ...
Lin H, Zhu J, Qu X, Lin S, Li S, Wang Y, Chen J, Wei R, Pan Y, Li X, Xu R, Huang S, Weng Y.   +12 more
europepmc   +2 more sources

Refining the treatment of immune checkpoint inhibitor–associated myocarditis: Challenges, innovations and rechallenge considerations

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitor (ICI)‐associated myocarditis has emerged as a severe and clinically complex immune‐related toxicity that poses significant challenges for therapeutic decision‐making in routine cardio‐oncological care. High‐dose corticosteroids remain the first‐line therapy, yet their timing, dosage and tapering require careful clinical ...
Raluca I. Mincu, Lisa Zimmer, Dimitra Vlachopoulou, Elias Haj‐Yehia, Julia Hoffmann, Lars Michel, Elisabeth Livingstone, Dirk Schadendorf, Alpaslan Tasdogan, Matthias Totzeck, Tienush Rassaf   +10 more
wiley   +1 more source

Myasthenia Gravis [PDF]

BMJ, 1959
openaire   +4 more sources

Immune checkpoint inhibitor‐induced arrhythmias: Mechanistic insights from clinical and preclinical studies

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, but their efficacy continues to be limited by immune‐related adverse events. Among these, ICI‐induced cardiac arrhythmias are increasingly recognised as a major adverse reaction, encompassing a broad spectrum of clinical phenotypes, including conduction blocks, atrial fibrillation and
Anand R. Ramalingam, Zoltán Márton Köhler, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

Arrhythmias associated with immune checkpoint inhibitor therapy—A clinical perspective

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have transformed cancer therapy but are associated with a growing spectrum of cardiovascular immune‐related adverse events. Among these, arrhythmias represent a rare yet potentially life‐threatening complication. ICI‐induced arrhythmias encompass a wide clinical spectrum, including atrial arrhythmias, conduction ...
Dong Wang, Melanie Ricke‐Hoch, David Duncker, Johann Bauersachs, Dominik Berliner   +4 more
wiley   +1 more source

Investigating the Risk Factors for Medication Nonadherence in Myasthenia Gravis Patients: Establishing a Nomogram Model

Patient Preference and Adherence
Chaoying Liu,1– 3 Simei Ning,1 Ping Lu,1,2 Wenli Jia,1 Xiaohe Zhang,1– 3 Guoyan Qi1– 31Treatment Center of Myasthenia Gravis, Shijiazhuang People’s Hospital, Shijiazhuang, Hebei, People’s Republic of China; 2Hebei Provincial Key Laboratory of Myasthenia ...
Liu C, Ning S, Lu P, Jia W, Zhang X, Qi G   +5 more
doaj